OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
Yue Xu, Tao Tao, Yong Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Yue Xu, Tao Tao, Yong Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Showing 11 citing articles:
Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer
Zhuolong Xiong, Zenglei Han, Weiyi Pan, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0286122-e0286122
Open Access | Times Cited: 12
Zhuolong Xiong, Zenglei Han, Weiyi Pan, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0286122-e0286122
Open Access | Times Cited: 12
Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6
Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
Wenhao Ouyang, Qing Peng, Zijia Lai, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27151-e27151
Open Access | Times Cited: 1
Wenhao Ouyang, Qing Peng, Zijia Lai, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27151-e27151
Open Access | Times Cited: 1
Identification and Functional Characterization of PI3K/Akt/mTOR Pathway-Related lncRNAs in Lung Adenocarcinoma: A Retrospective Study.
Jiaqi Zhong, Ying Kong, Ruming Li, et al.
PubMed (2024) Vol. 26, Iss. 1, pp. 13-27
Closed Access | Times Cited: 1
Jiaqi Zhong, Ying Kong, Ruming Li, et al.
PubMed (2024) Vol. 26, Iss. 1, pp. 13-27
Closed Access | Times Cited: 1
Exploring the modulation of TLR4 and its associated ncRNAs in cancer immunopathogenesis, with an emphasis on the therapeutic implications and mechanisms underlying drug resistance
Mohammad Y. Alshahrani, Enwa Felix Oghenemaro, Jasur Rizaev, et al.
Human Immunology (2024) Vol. 86, Iss. 1, pp. 111188-111188
Closed Access | Times Cited: 1
Mohammad Y. Alshahrani, Enwa Felix Oghenemaro, Jasur Rizaev, et al.
Human Immunology (2024) Vol. 86, Iss. 1, pp. 111188-111188
Closed Access | Times Cited: 1
A ferroptosis‐related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study
Jiaxin Dong, Tao Tao, Jiaao Yu, et al.
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Jiaxin Dong, Tao Tao, Jiaao Yu, et al.
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Computational identification of long non-coding RNAs associated with graphene therapy in glioblastoma multiforme
Zhuoheng Zou, Ming Zhang, Shang Zhong Xu, et al.
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Zhuoheng Zou, Ming Zhang, Shang Zhong Xu, et al.
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma
Xiaojian Shen, Jing Xie, Shu Liu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 8, pp. 5361-5378
Open Access
Xiaojian Shen, Jing Xie, Shu Liu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 8, pp. 5361-5378
Open Access
Predicting pan-cancer immune-checkpoint therapy and prognosis with a chromatin-accessibility-related alternative splicing signature: a retrospective study
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
Development and application of a predictive model for survival and drug therapy based on COVID-19-related lncRNAs in non-small cell lung cancer
Ziyuan Huang, Zenglei Han, Kairong Zheng, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40629-e40629
Open Access
Ziyuan Huang, Zenglei Han, Kairong Zheng, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40629-e40629
Open Access
